Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New skin serum passes safety check in small trial

NCT ID NCT07517900

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study tested whether a topical serum containing Mitopure is safe for healthy adults. Forty participants applied the serum repeatedly over two weeks. Researchers checked for skin irritation and asked about product traits. The trial focused only on safety, not on whether the serum improves skin appearance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mitopure topical serum
What this could lead to
If successful, this could support the development of a safe skin serum for cosmetic use.
What could go wrong
This is a small, early safety study in healthy people, not designed to test effectiveness. Results may not apply to people with skin conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Apr 2026

Finished

May 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy male and female participants aged 18+. * Participant has signed a written Informed Consent. * Participant must agree to refrain from taking any new medications or herbal supplements during the study, unless permitted by the investigator. * Participant does not have grade of 3 or higher of any skin attribute per the grading scale. * Participant is willing to ONLY use the test article on themselves during the study as instructed and not use other facial serum products. * Participant is willing to attend all study visits and to follow the study instructions and prohibitions. * Participant must agree to refrain from using any new facial serum products, cleansers, laundry detergents, fragrances while participating in this study. Exclusion Criteria: * Participant is pregnant, nursing, or planning to become pregnant (by verbal response only). * Participant has a current skin disease of any type (e.g., eczema, psoriasis, rosacea, atopic dermatitis, vitiligo). * Participant has a known allergy to face serum products, or the ingredients included in the test article. * Participant has a history of malignant disease. * Participant has cuts, scratches, abrasions, rashes, scarring, birthmarks, or tattoos on their face that may interfere with assessments. * Participant has a significant past medical history of hepatic, renal, cardiac, pulmonary, digestive, haematological, neurological, locomotor or psychiatric disease. * Participant has a known sensitivity to the test article, similar materials, or their constituents. * Treatment or medication containing sympathomimetics, antihistamines or corticosteroids in the seven days prior to study start. * Medical condition that may affect study data or participant safety which in the opinion of the Investigator would compromise the safety of the participant or study results. * History of poor cooperation, non-compliance, or unreliability. * Investigator deems the participant an unsuitable candidate for the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • PCR Corp

    Manchester, M13 0AF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.